Gabelli & Co Investment Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-137,232	Closed	-$4.56M	–	315
2022 Q4	$4.56M	Buy	137,232 +30,800	+29%	+$992K	0.97%	29
2022 Q3	$3.36M	Buy	+106,432	New	+$3.45M	0.44%	49

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's VIVO Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 137,232 shares — an estimated $4.56M sold.

Gabelli & Co Investment Advisers first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $4.56M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Gabelli & Co Investment Advisers reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 137,232 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.56M.
Gabelli & Co Investment Advisers first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Gabelli & Co Investment Advisers's Meridian Bioscience Inc position peaked at $4.56M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.